-+ 0.00%
-+ 0.00%
-+ 0.00%

PROPANC BIOPHARMA INC - PLANS TWO PHASE 2 STUDIES IN PANCREATIC AND OVARIAN CANCERS WITH 60 PATIENTS EACH

Reuters·05/20/2026 12:45:51

Please log in to view news